(Q73743067)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10794820%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Effects of WAY 100635 on antipsychotic-induced catalepsy in 5-HT depleted animals: a role for tonic activation of 5-HT(1A) receptors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10794820%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Prinssen EP

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10794820%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Koek W

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10794820%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Kleven MS

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10794820%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10794820%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10794820%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

395

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10794820%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10794820%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

143-147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10794820%20AND%20SRC:MED&resulttype=core&format=json

Biphasic displacement of [3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

Serotonin, schizophrenia and antipsychotic drug action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

Reversal of haloperidol-induced extrapyramidal side effects in cebus monkeys by 8-hydroxy-2-(di-n-propylamino)tetralin and its enantiomers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

Clozapine decreases serotonin extracellular levels in the nucleus accumbens by a dopamine receptor-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

Characteristics and risk factors of acute dystonia in schizophrenic patients treated with nemonapride, a selective dopamine antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

Effect of p-chlorophenylalanine on release of 5-hydroxytryptamine from the rat frontal cortex in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

The cataleptogenic effects of the neuroleptic nemonapride are attenuated by its 5-HT1A receptor agonist properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

Interactions between neuroleptics and 5-HT(1A) ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

Development of 5-HT1A receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

Effect of tandospirone on tardive dyskinesia and parkinsonian symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900178-3

10.1016/S0014-2999(00)00178-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10794820%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference